Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 160 articles:
HTML format
Text format



Single Articles


    July 2018
  1. HULSHOF L, Hack DP, Hasnoe QCJ, Dontje B, et al
    Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children.
    Br J Dermatol. 2018 Jul 10. doi: 10.1111/bjd.16994.
    PubMed     Text format     Abstract available


  2. THYSSEN JP, Egeberg A
    Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16939.
    PubMed     Text format     Abstract available


  3. TSAKOK T, Woolf R, Smith CH, Weidinger S, et al
    Atopic dermatitis: the skin barrier and beyond.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16934.
    PubMed     Text format     Abstract available


  4. BRANDWEIN M, Fuks G, Israel A, Nejman D, et al
    Identification of a unique Staphylococcus aureus ribosomal signature in severe atopic dermatitis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16936.
    PubMed     Text format     Abstract available


    June 2018
  5. AHLSTROM MG, Thyssen JP, Menne T, Midander K, et al
    Short contact with nickel causes allergic contact dermatitis: an experimental study.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16935.
    PubMed     Text format     Abstract available


  6. MOCHIZUKI H, Lavery MJ, Nattkemper LA, Albornoz C, et al
    Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16921.
    PubMed     Text format     Abstract available


  7. KALAKI E, Mizara A
    The role of parenting experiences, rather than age of onset or presence of the skin condition, in the development of maladaptive schemas in a community sample of patients with atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16920.
    PubMed     Text format     Abstract available


  8. HURAULT G, Schram ME, Roekevisch E, Spuls PI, et al
    Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16916.
    PubMed     Text format     Abstract available


  9. DRUCKER AM, Flohr C
    Revisiting atopic dermatitis and cardiovascular disease.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16891.
    PubMed     Text format     Abstract available


  10. VON KOBYLETZKI LB, Svensson A
    Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    Br J Dermatol. 2018;178:1236-1237.
    PubMed     Text format    


  11. SEDDON O, Hughes H
    Staphylococcus aureus and atopic dermatitis: a complex relationship.
    Br J Dermatol. 2018;178:1234.
    PubMed     Text format    


  12. DRUCKER AM, Flohr C
    Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?
    Br J Dermatol. 2018;178:1235-1236.
    PubMed     Text format    


    May 2018
  13. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Text format     Abstract available


  14. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Text format     Abstract available


  15. SCHMITT J
    After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    Br J Dermatol. 2018;178:992-993.
    PubMed     Text format    


    April 2018
  16. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Text format     Abstract available


  17. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Text format     Abstract available


  18. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed     Text format    


  19. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed     Text format    


    March 2018
  20. ROLLS S, Rajan S, Shah A, Bourke JF, et al
    (Meth)acrylate allergy: frequently missed?
    Br J Dermatol. 2018 Mar 10. doi: 10.1111/bjd.16402.
    PubMed     Text format    


  21. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed     Text format    


  22. UTER W
    Extended patch-test screening for fragrance contact allergy: findings and challenges.
    Br J Dermatol. 2018;178:592-593.
    PubMed     Text format    


    February 2018
  23. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Text format     Abstract available


  24. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed     Text format    


  25. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed     Text format    


    January 2018
  26. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Text format     Abstract available


  27. KONO M, Akiyama M, Inoue Y, Nomura T, et al
    Filaggrin gene mutations may influence the persistence of food allergies in Japanese primary school children.
    Br J Dermatol. 2018 Jan 25. doi: 10.1111/bjd.16375.
    PubMed     Text format     Abstract available


  28. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Text format     Abstract available


  29. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Text format     Abstract available


  30. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Text format     Abstract available


  31. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Text format     Abstract available


    December 2017
  32. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Text format     Abstract available


  33. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Text format     Abstract available


  34. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Text format     Abstract available


  35. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Text format     Abstract available


  36. VAN DER BENT SAS, Maijer KI, Rustemeyer T
    Image Gallery: Hyperkeratotic hypersensitivity reaction to red pigment tattoo.
    Br J Dermatol. 2017;177:e350.
    PubMed     Text format    


    November 2017
  37. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Text format     Abstract available


  38. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed     Text format    


  39. DE BRUIN-WELLER M, Thaci D, Smith CH, Reich K, et al
    Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized ph
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16156.
    PubMed     Text format     Abstract available


  40. RUFF SMD, Engebretsen KA, Zachariae C, Johansen JD, et al
    The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16147.
    PubMed     Text format     Abstract available


  41. NAKAMURA-NISHIMURA Y, Miyagawa F, Miyashita K, Ommori R, et al
    Serum thymus and activation-regulated chemokine (TARC) is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS).
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16132.
    PubMed     Text format     Abstract available


  42. DANBY SG
    Staphylococcus aureus in atopic dermatitis: a diverse problem?
    Br J Dermatol. 2017;177:1164.
    PubMed     Text format    


  43. DRUCKER AM
    Making sense of measures of clinical signs for atopic dermatitis.
    Br J Dermatol. 2017;177:1158-1159.
    PubMed     Text format    


  44. SILVERBERG JI
    Are moisturizers effective in the treatment of atopic dermatitis?
    Br J Dermatol. 2017;177:1154.
    PubMed     Text format    


    October 2017
  45. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  46. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


  47. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    


  48. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    


    September 2017
  49. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  50. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  51. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


  52. WEIDINGER S, Baurecht H, Schmitt J
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15827.
    PubMed     Text format     Abstract available


  53. DRUCKER AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, et al
    Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15928.
    PubMed     Text format     Abstract available


    August 2017
  54. CHARMAN C
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
    Br J Dermatol. 2017 Aug 31. doi: 10.1111/bjd.15848.
    PubMed     Text format    


  55. TSIANAKAS A, Luger TA, Radin A
    Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15905.
    PubMed     Text format     Abstract available


  56. HARRIS V, Smith SD
    Lifting the biofilm lid on the antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus in atopic dermatitis.
    Br J Dermatol. 2017;177:347-348.
    PubMed     Text format    


  57. SAMUEL RJ, Reynolds NJ
    Ustekinumab for severe atopic dermatitis: an important negative study.
    Br J Dermatol. 2017;177:339-341.
    PubMed     Text format    


    July 2017
  58. JACOB SE
    Percutaneous absorption risks in atopic dermatitis.
    Br J Dermatol. 2017;177:11-12.
    PubMed     Text format    


    June 2017
  59. LOWE AJ, Su JC, Allen KJ, Abramson MJ, et al
    A randomised trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitisation: The PEBBLES Pilot Study.
    Br J Dermatol. 2017 Jun 22. doi: 10.1111/bjd.15747.
    PubMed     Text format     Abstract available


  60. DRUCKER AM, Qureshi AA, Dummer TJB, Parker L, et al
    Atopic dermatitis and risk of hypertension, type-2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15727.
    PubMed     Text format     Abstract available


  61. BALATO A, Caiazzo G
    Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis.
    Br J Dermatol. 2017;176:1437-1438.
    PubMed     Text format    


  62. DRUCKER AM
    Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Br J Dermatol. 2017;176:1441-1442.
    PubMed     Text format    


  63. AGNER T
    Biomarkers in contact dermatitis.
    Br J Dermatol. 2017;176:1434-1435.
    PubMed     Text format    


    May 2017
  64. CHOPRA R, Vakharia PP, Sacotte R, Patel N, et al
    Severity strata for EASI, mEASI, oSCORAD, SCORAD, ADSI and BSA in adolescents and adults with atopic dermatitis.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15641.
    PubMed     Text format     Abstract available


  65. SIMONSEN AB, Johansen JD, Deleuran M, Mortz CG, et al
    Contact allergy in children with atopic dermatitis: a systematic review.
    Br J Dermatol. 2017 May 3. doi: 10.1111/bjd.15628.
    PubMed     Text format     Abstract available


    April 2017
  66. CHEOK S, Yee F, Ma JYS, Leow R, et al
    Prevalence and Descriptive Epidemiology of Atopic Dermatitis and Its Impact on Quality of Life in Singapore.
    Br J Dermatol. 2017 Apr 17. doi: 10.1111/bjd.15587.
    PubMed     Text format     Abstract available


  67. CHANSKY PB, Mittal L, Werth VP
    Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:853-854.
    PubMed     Text format    


  68. NALDI L
    Finding a HOME for outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:852-853.
    PubMed     Text format    


  69. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


  70. SPULS PI, Gerbens LAA, Simpson E, Apfelbacher CJ, et al
    Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
    Br J Dermatol. 2017;176:979-984.
    PubMed     Text format     Abstract available


  71. NANKERVIS H, Thomas KS, Delamere FM, Barbarot S, et al
    What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.
    Br J Dermatol. 2017;176:910-927.
    PubMed     Text format     Abstract available


  72. KHANDPUR S, Porter RM, Boulton SJ, Anstey A, et al
    Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.
    Br J Dermatol. 2017;176:902-909.
    PubMed     Text format     Abstract available


  73. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    


    March 2017
  74. SAEKI H, Kabashima K, Tokura Y, Murata Y, et al
    Efficacy and Safety of Ustekinumab in Japanese Patients with Severe Atopic Dermatitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study.
    Br J Dermatol. 2017 Mar 24. doi: 10.1111/bjd.15493.
    PubMed     Text format     Abstract available


  75. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15489.
    PubMed     Text format     Abstract available


  76. RAMZY AG, Lammintausta K, Matura M, B Christensson J, et al
    Isothiocyanates are important as haptens in contact allergy to chloroprene rubber.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15444.
    PubMed     Text format     Abstract available


    February 2017
  77. LI S, Villarreal M, Stewart S, Choi J, et al
    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 28. doi: 10.1111/bjd.15409.
    PubMed     Text format     Abstract available


  78. ERIKSSON S, van der Plas MJ, Morgelin M, Sonesson A, et al
    Antibacterial and anti-biofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis.
    Br J Dermatol. 2017 Feb 26. doi: 10.1111/bjd.15410.
    PubMed     Text format     Abstract available


  79. CHANG J, Bilker WB, Hoffstad O, Margolis DJ, et al
    Cross-Sectional Comparisons of Patient-Reported Disease Control, Disease Severity, and Symptom Frequency in Children with Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15403.
    PubMed     Text format     Abstract available


  80. DYBBOE R, Bandier J, Skov L, Engstrand L, et al
    The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15390.
    PubMed     Text format     Abstract available


  81. PEETERS C, Herman A, Baeck M
    Donkey's milk allergy.
    Br J Dermatol. 2017 Feb 11. doi: 10.1111/bjd.15367.
    PubMed     Text format     Abstract available


  82. SU JC, Dailey R, Zallmann M, Leins E, et al
    Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric cross over study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15376.
    PubMed     Text format     Abstract available


  83. LINDBERG M, Soderquist B
    Atopic dermatitis and gut microbiota.
    Br J Dermatol. 2017;176:297-298.
    PubMed     Text format    


  84. TAN CW, Pang Y, Sim B, Thirumoorthy T, et al
    The association between drugs and bullous pemphigoid.
    Br J Dermatol. 2017;176:549-551.
    PubMed     Text format    


  85. STROM MA, Silverberg JI
    Association between atopic dermatitis and extracutaneous infections in US adults.
    Br J Dermatol. 2017;176:495-497.
    PubMed     Text format    


  86. THANDAR Y, Gray A, Botha J, Mosam A, et al
    Topical herbal medicines for atopic eczema: a systematic review of randomized controlled trials.
    Br J Dermatol. 2017;176:330-343.
    PubMed     Text format     Abstract available


  87. YE YM, Hur GY, Kim SH, Ban GY, et al
    Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome.
    Br J Dermatol. 2017;176:378-386.
    PubMed     Text format     Abstract available


  88. VACCARO M, Santarpia M, Calapai G, Mannucci C, et al
    Mucocutaneous toxicity induced by pegylated liposomal doxorubicin: a single-institution, retrospective case series.
    Br J Dermatol. 2017;176:507-509.
    PubMed     Text format    


  89. LEE HY, Walsh SA, Creamer D
    Long term complications of Stevens-Johnson syndrome / Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15360.
    PubMed     Text format     Abstract available


    January 2017
  90. MUGHAL AA
    What substances are allergenic and in whom?
    Br J Dermatol. 2017;176:14-15.
    PubMed     Text format    


  91. BISHNOI A, Parsad D, Vinay K, Kumaran MS, et al
    Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study.
    Br J Dermatol. 2017;176:62-70.
    PubMed     Text format     Abstract available


  92. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  93. GORCZYZA M, Schoepke N, Krause K, Hawro T, et al
    Patients with chronic cold urticaria may benefit from doxycycline therapy.
    Br J Dermatol. 2017;176:259-261.
    PubMed     Text format    


  94. VOLKER-TOUW CM, de Koning HD, Giltay JC, de Kovel CG, et al
    Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype.
    Br J Dermatol. 2017;176:244-248.
    PubMed     Text format    


  95. THOMSEN SF
    Effectiveness of phototherapy in chronic urticaria.
    Br J Dermatol. 2017;176:8.
    PubMed     Text format    


    December 2016
  96. ZHAO CY, Hao EY, Oh DD, Daniel BS, et al
    A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate to dark skin patients.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15271.
    PubMed     Text format     Abstract available


  97. BENSEFA-COLAS L, Stocks SJ, McNamee R, Faye S, et al
    Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15261.
    PubMed     Text format     Abstract available


  98. NIC DHONNCHA E, Clowry J, Dunphy M, Buckley C, et al
    Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15262.
    PubMed     Text format     Abstract available


  99. HERMS F, Franck N, Kramkimel N, Fichel F, et al
    Neutrophilic eccrine hidradenitis in 2 patients treated with BRAF inhibitors: a new cutaneous adverse event.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15259.
    PubMed     Text format     Abstract available


  100. HELANDER A, Bradley M, Hasselblad A, Norlen L, et al
    Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15174.
    PubMed     Text format     Abstract available


    November 2016
  101. ROEKEVISCH E, Leeflang MM, Schram ME, Campbell LE, et al
    Atopic dermatitis patients with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15191.
    PubMed     Text format     Abstract available


  102. BENNIKE NH, Zachariae C, Duus Johansen J
    Trends in contact allergy to fragrance mix I in consecutive Danish eczema patients over three decades; a cross-sectional study from 1986 to 2015.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15180.
    PubMed     Text format     Abstract available


  103. GONZALEZ-LOPEZ G, Ceballos-Rodriguez RM, Gonzalez-Lopez JJ, Feito Rodriguez M, et al
    Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Nov 8. doi: 10.1111/bjd.15165.
    PubMed     Text format     Abstract available


  104. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  105. BERENTS TL, Lodrup Carlsen KC, Mowinckel P, Skjerven HO, et al
    Transepidermal water loss in infancy associated with atopic eczema at 2 years: a population-based cohort study.
    Br J Dermatol. 2016 Nov 3. doi: 10.1111/bjd.15157.
    PubMed     Text format     Abstract available


  106. DAMSKY W, King BA
    STATing the obvious: it's time for new treatments in atopic dermatitis.
    Br J Dermatol. 2016;175:861-862.
    PubMed     Text format    


  107. EDWARDS C
    Measurements of structure and function of skin: emollient effects on atopic dermatitis.
    Br J Dermatol. 2016;175:868-869.
    PubMed     Text format    


  108. STROM MA, Fishbein AB, Paller AS, Silverberg JI, et al
    Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
    Br J Dermatol. 2016;175:920-929.
    PubMed     Text format     Abstract available


  109. TAKEHARA A, Aoyama Y, Kurosawa M, Shirafuji Y, et al
    Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;175:944-952.
    PubMed     Text format     Abstract available


  110. TOMIDA E, Kato Y, Ozawa H, Hasegawa H, et al
    Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2016;175:1106-1108.
    PubMed     Text format    


    October 2016
  111. HEPBURN L, Hijnen DJ, Sellman BR, Mustelin T, et al
    The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
    Br J Dermatol. 2016 Oct 25. doi: 10.1111/bjd.15139.
    PubMed     Text format     Abstract available


  112. NOWROUZIAN FL, Lina G, Hodille E, Lindberg E, et al
    Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema.
    Br J Dermatol. 2016 Oct 19. doi: 10.1111/bjd.15138.
    PubMed     Text format     Abstract available


    September 2016
  113. HALLING-OVERGAARD AS, Kezic S, Jakasa I, Engebretsen KA, et al
    Skin absorption through atopic dermatitis skin: a systematic review.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15065.
    PubMed     Text format     Abstract available


  114. ORCIANI M, Campanati A, Caffarini M, Ganzetti G, et al
    Th1 -Th17 and Th2 imbalance in Mesenchymal Stem Cells of adult patients with atopic dermatitis: at the origin of the problem.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15078.
    PubMed     Text format     Abstract available


    August 2016
  115. VENABLES ZC, Bourke JF, Buckley DA, Campbell F, et al
    Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak?
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15016.
    PubMed     Text format     Abstract available


  116. LEE UH, Kim BE, Kim DJ, Cho YG, et al
    Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration.
    Br J Dermatol. 2016 Aug 30. doi: 10.1111/bjd.15010.
    PubMed     Text format     Abstract available


  117. MOSE KF, Andersen F, Skov L, Ropke MA, et al
    Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14949.
    PubMed     Text format     Abstract available


  118. PAPO M, Valeyrie-Allanore L, Razazi K, Carteaux G, et al
    Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14934.
    PubMed     Text format     Abstract available


  119. KIM J, Han Y, Ahn JH, Kim SW, et al
    Airborne formaldehyde causes skin barrier dysfunction in atopic dermatitis.
    Br J Dermatol. 2016;175:357-63.
    PubMed     Text format     Abstract available


  120. WALSH S, Lew T, Lee HY
    Psychological sequelae of toxic epidermal necrolysis: further insights.
    Br J Dermatol. 2016;175:241.
    PubMed     Text format    


    July 2016
  121. BISSONNETTE R, Papp KA, Poulin Y, Gooderham M, et al
    Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial.
    Br J Dermatol. 2016 Jul 16. doi: 10.1111/bjd.14871.
    PubMed     Text format     Abstract available


  122. CHONG HT, Yang GN, Sidhu S, Ibbetson J, et al
    Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14842.
    PubMed     Text format     Abstract available


  123. MOLIN S
    Deciphering the lipidomic profile of irritant contact dermatitis.
    Br J Dermatol. 2016;175:20-1.
    PubMed     Text format    


    June 2016
  124. LYNCH MD, White JM, McFadden JP, Wang Y, et al
    A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity.
    Br J Dermatol. 2016 Jun 10. doi: 10.1111/bjd.14793.
    PubMed     Text format     Abstract available


  125. CREAMER D, Walsh SA, Dziewulski P, Exton LS, et al
    U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Br J Dermatol. 2016;174:1194-227.
    PubMed     Text format    


  126. WOLKENSTEIN P, Wilson YT
    Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.
    Br J Dermatol. 2016;174:1171-3.
    PubMed     Text format    


    May 2016
  127. PETRELLI F, Borgonovo K, Cabiddu M, Coinu A, et al
    Antibiotic prophylaxis for skin toxicity induced by anti-EGFR agents: a systematic review and meta-analysis.
    Br J Dermatol. 2016 May 23. doi: 10.1111/bjd.14756.
    PubMed     Text format     Abstract available


  128. PONGPAIROJ K, McFadden JP, Basketter DA
    Advice for patients with hair dye allergy remains 'stop using permanent hair dyes'.
    Br J Dermatol. 2016;174:957-8.
    PubMed     Text format    


  129. LAPI F, Cassano N, Pegoraro V, Cataldo N, et al
    Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.
    Br J Dermatol. 2016;174:996-1004.
    PubMed     Text format     Abstract available


  130. ZIMMER S, Peveling-Oberhag A, Weber A, Gilfert T, et al
    Unique coexistence of cold and solar urticaria and its efficient treatment.
    Br J Dermatol. 2016;174:1150-2.
    PubMed     Text format    


  131. HAWKEY S, Abdul Ghaffar S
    Glove-related hand urticaria: an increasing occupational problem among healthcare workers.
    Br J Dermatol. 2016;174:1137-40.
    PubMed     Text format    


    April 2016
  132. SAWATKAR GU, Sahu KK, Prakash G, Dogra S, et al
    Image Gallery: Flagellate dermatitis.
    Br J Dermatol. 2016;174:e23.
    PubMed     Text format    


  133. PARISER DM, Eichenfield LF, Bukhalo M, Waterman G, et al
    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Br J Dermatol. 2016;174:770-7.
    PubMed     Text format     Abstract available


  134. MAURER M, Staubach P, Raap U, Richter-Huhn G, et al
    ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.
    Br J Dermatol. 2016;174:892-4.
    PubMed     Text format    


    March 2016
  135. CHON SY, Hassler AA
    Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy.
    Br J Dermatol. 2016;174:686-7.
    PubMed     Text format    


  136. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


  137. KURATA M, Horie C, Kano Y, Shiohara T, et al
    Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;174:681-3.
    PubMed     Text format    


  138. BENNETT MF, Lowney AC, Bourke JF
    A study of occupational contact dermatitis in the pharmaceutical industry.
    Br J Dermatol. 2016;174:654-6.
    PubMed     Text format    


  139. DAUNTON A, Bridgett C, Goulding JM
    Habit reversal for refractory atopic dermatitis: a review.
    Br J Dermatol. 2016;174:657-9.
    PubMed     Text format    


    February 2016
  140. HASHIMOTO T, Ohzono A, Ishii N
    'Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus': reply from the authors.
    Br J Dermatol. 2016;174:461-2.
    PubMed     Text format    


  141. AMBER KT
    Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:461.
    PubMed     Text format    


  142. BROWN SJ
    Hand dermatitis in construction workers: a lesson in genetic epidemiology.
    Br J Dermatol. 2016;174:263-5.
    PubMed     Text format    


  143. HAUKSSON I, Ponten A, Gruvberger B, Isaksson M, et al
    Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Br J Dermatol. 2016;174:371-9.
    PubMed     Text format     Abstract available


  144. TIMMERMAN JG, Heederik D, Spee T, van Rooy FG, et al
    Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.
    Br J Dermatol. 2016;174:348-55.
    PubMed     Text format     Abstract available


  145. NEMOTO O, Furue M, Nakagawa H, Shiramoto M, et al
    The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placeb
    Br J Dermatol. 2016;174:296-304.
    PubMed     Text format     Abstract available


  146. DIEPGEN TL, Ofenloch RF, Bruze M, Bertuccio P, et al
    Prevalence of contact allergy in the general population in different European regions.
    Br J Dermatol. 2016;174:319-29.
    PubMed     Text format     Abstract available


  147. STINGENI L, Bianchi L, Tramontana M, Moretta I, et al
    Indoor dermatitis due to Aeroglyphus robustus.
    Br J Dermatol. 2016;174:454-6.
    PubMed     Text format    


  148. SCHLIPF NA, Vahlquist A, Teigen N, Virtanen M, et al
    Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.
    Br J Dermatol. 2016;174:444-8.
    PubMed     Text format    


    January 2016
  149. LIN CH, Wei CC, Lin CL, Lin WC, et al
    Childhood type 1 diabetes may increase the risk of atopic dermatitis.
    Br J Dermatol. 2016;174:88-94.
    PubMed     Text format     Abstract available


  150. TSUTSUMI M, Kitahata H, Fukuda M, Kumamoto J, et al
    Numerical and comparative three-dimensional structural analysis of peripheral nerve fibres in epidermis of patients with atopic dermatitis.
    Br J Dermatol. 2016;174:191-4.
    PubMed     Text format    


  151. POLITIEK K, van der Schaft J, Coenraads PJ, de Bruin-Weller MS, et al
    Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
    Br J Dermatol. 2016;174:201-3.
    PubMed     Text format    


    November 2015
  152. VINTER H, Kragballe K, Steiniche T, Gaestel M, et al
    TNFalpha plays a significant role in the Aldara-induced skin inflammation in mice.
    Br J Dermatol. 2015 Nov 28. doi: 10.1111/bjd.14320.
    PubMed     Text format     Abstract available


    September 2015
  153. CARRASCOSA R, Llamas-Velasco M, Montes-Torres A, Sanchez-Perez J, et al
    Does boceprevir really increase the risk of skin eruptions during antihepatitis C treatment?
    Br J Dermatol. 2015 Sep 15. doi: 10.1111/bjd.14169.
    PubMed     Text format     Abstract available


    July 2015
  154. WU J, Lee YY, Su SC, Wu TS, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in patients with malignancies.
    Br J Dermatol. 2015 Jul 27. doi: 10.1111/bjd.14052.
    PubMed     Text format     Abstract available


    June 2015
  155. MALERBA M, Damiani G, Radaeli A, Ragnoli B, et al
    Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma.
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13988.
    PubMed     Text format     Abstract available


  156. PIRMEZ R, Fernandes AL, Melo MG
    Photoaggravated contact dermatitis to Kathon CG (methylchloroisothiazolinone/methylisothiazolinone): a novel pattern of involvement in a growing epidemic?
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13986.
    PubMed     Text format     Abstract available


  157. SINHA R, Larkin J, Gore M, Fearfield L, et al
    Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Br J Dermatol. 2015 Jun 24. doi: 10.1111/bjd.13958.
    PubMed     Text format     Abstract available


    April 2015
  158. DE KONING HD, van Vlijmen-Willems IM, Rodijk-Olthuis D, van der Meer JW, et al
    Mast cell interleukin-1 beta, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome.
    Br J Dermatol. 2015 Apr 22. doi: 10.1111/bjd.13857.
    PubMed     Text format     Abstract available


    March 2015
  159. ALLOO A, Sheu J, Butrynski JE, DeAngelo DJ, et al
    Ponatinib-Induced Pityriasiform, Folliculocentric and Ichthyosiform Cutaneous Toxicities.
    Br J Dermatol. 2015 Mar 4. doi: 10.1111/bjd.13692.
    PubMed     Text format     Abstract available


  160. CHENG L, Xiong Y, Qin CZ, Zhang W, et al
    HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2015 Mar 2. doi: 10.1111/bjd.13688.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: